SEC Form 5 · accession 0001140361-15-002062
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward O Lanphier II
Officer — President & CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 16, 2015 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F4 | Jun 16, 2014 | G | 400,000 | $0.00 | D | 1,204,521 | I | By Trust |
| Common StockF2,F4 | Dec 10, 2014 | G | 13,500 | $0.00 | D | 1,191,021 | I | By Trust |
| Common StockF2,F4 | Dec 15, 2014 | G | 2,000 | $0.00 | D | 1,189,021 | I | By Trust |
| Common StockF2,F3 | holding | — | — | — | 235,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were transferred as a bona fide gift without consideration.
- F2Includes 60,000, 50,000 shares and 125,000 subject to RSUs granted on December 6, 2012, December 12, 2013 and December 11, 2014, respectively, that will be issued as such units vest in accordance with their terms.
- F3On December 16, 2014, the Reporting Person transferred 88,467 shares directly held by him to the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees ("Lanphier Trust").
- F4These shares are held in the Lanphier Trust.